Navigation Links
Antibodies from the desert as guides to diseased cells
Date:6/12/2014

The use of nanoparticles in cancer research is considered as a promising approach in detecting and fighting tumour cells. The method has, however, often failed because the human immune system recognizes the particles as foreign objects and rejects them before they can fulfil their function. Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and at University College Dublin in Ireland have, along with other partners, developed nanoparticles that not only bypass the body's defence system, but also find their way to the diseased cells. This procedure uses fragments from a particular type of antibody that only occurs in camels and llamas. The small particles were even successful under conditions which are very similar to the situation within potential patients' bodies.

Describing the current state of research, Dr. Kristof Zarschler of the Helmholtz Virtual Institute NanoTracking at the HZDR explains, "At the moment we must overcome three challenges. First, we need to produce the smallest possible nanoparticles. We then need to modify their surface in a way that the proteins in the human bodies do not envelop them, which would thus render them ineffective. In order to ensure, that the particles do their job, we must also somehow program them to find the diseased cells." Therefore, the Dresden and Dublin researchers combined expertise to develop nanoparticles made of silicon dioxide with fragments of camel antibodies.

In contrast to conventional antibodies, which consist of two light and two heavy protein chains, those taken from camels and llamas are less complex and are made up of only two heavy chains. "Due to this simplified structure, they are easier to produce than normal antibodies," explains Zarschler. "We also only need one particular fragment the portion of the molecule that binds to certain cancer cells which makes the production of much smaller nanoparticles possible." By modifying the surface of the nanoparticle, it also gets more difficult for the immune system to recognize the foreign material, which allows the nanoparticles to actually reach their target.

The ultra-small particles should then detect the so-called epidermal growth factor receptor (EGFR) in the human body. In various types of tumours, this molecule is overexpressed and/or exists in a mutated form, which allows the cells to grow and multiply uncontrollably. The Dresden researchers could demonstrate in experiments that nanoparticles that have been combined with the camel antibody fragments can more firmly bind to the cancer cells. "The EGFR is a virtual lock to which our antibody fits like a key," explains Zarschler.

They even obtained the same results in experiments involving human blood serum a biologically relevant environment the scientists point out: "This means that we carried out the tests under conditions that are very similar to the reality of the human body," explains Dr. Holger Stephan, who leads the project. "The problem with many current studies is that artificial conditions are chosen where no disruptive factors exist. While this provides good results, it is ultimately useless because the nanoparticles fail finally in experiments conducted under more complex conditions. In our case, we could at least reduce this error source."

However, more time is required before the nanoparticles can be utilized in diagnosing human tumours. "The successful tests have brought us one step further," explains Stephan. "The road, however, to its clinical use is long." The next aim is to reduce the size of the nanoparticles, which are now approximately fifty nanometres in diameter, to less than ten nanometres. "That would be optimal," according to Zarschler. "Then they would only remain in the human body for a short period just long enough to detect the tumour."
'/>"/>

Contact: Simon Schmitt
s.schmitt@hzdr.de
49-351-260-3400
Helmholtz-Zentrum Dresden-Rossendorf
Source:Eurekalert

Related medicine news :

1. NIH grantees sharpen understanding of antibodies that may cut risk of HIV infection
2. NIH scientists find mechanism that helps HIV evade antibodies, stabilize key proteins
3. Monoclonal Antibodies Market in Gastric and Esophageal Cancers to Reach USD 766 Mln by 2019, Says GBI Research in Its Report Available at MarketPublishers.com
4. Higher mortality in postmenopausal women with RA and anti-CCP antibodies
5. Maine Biotechnology Services-USDA-ARS Partnership Provides Monoclonal Antibodies to Aid in the Containment of Rift Valley Fever Virus
6. Ben-Gurion U. and Sorrento Therapeutics sign agreement to develop anti-hepatitis C virus antibodies
7. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
8. Monoclonal Antibodies Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research
9. Research reveals how antibodies neutralize mosquito-borne virus
10. Genetically modified tobacco plants produce antibodies to treat rabies
11. NIH scientists identify protective role for antibodies in Ebola vaccine study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s ... honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD ... elite group of providers. , Produced by Zeltiq, CoolSculpting is approved by the ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... joined the Peoples Health network on Dec. 1, 2016. Peoples Health, a Metairie-based ... Medical Center is an exciting addition to our provider network, and the addition ...
(Date:1/17/2017)... ... 2017 , ... A prescription medication bottle, pocket knife, luggage and a solar-powered ... Product Design Challenge , the Cradle to Cradle Products Innovation Institute has ... scheduled to run through early 2018. The challenges are presented by the Institute in ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Neil H. ... financial planning assistance to communities throughout the region, is launching a charity drive to ... disease is by far the deadliest killer in America, and is responsible for 1 ...
(Date:1/17/2017)... ... 2017 , ... SC&H Group, a leading audit, tax, and consulting firm, announced ... Advisory Services practice . Rossi is the third technology consulting leader to join SC&H ... grows, and the practice continues to expand.     , Bringing more than 25 years of ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 18, 2017  Robust competition in the private ... on medicine prices, according to a new study ... is among the first to examine the share of ... pharmacy benefit managers (PBMs), health plans and other stakeholders ... is the first to show what happens when the ...
(Date:1/18/2017)... Chinese Food and Drug Administration CSL CureVac ... Food and Drug Administration FORT Fresenius Pharmaceuticals ... Glaxo Smith Klein GlaxoWellcome Global Influenza Programme ... Immune Targeting Systems Indian Association of Paediatrics ... Johnson & Johnson Krka Pharmaceuticals Medicago ...
(Date:1/17/2017)... , Jan. 17, 2017 North America ... GlobalData,s new report, "North America Insulin Delivery Market Outlook ... America Insulin Delivery market. The report provides value, in ... prices (USD) within market segments - Insulin Pens, Insulin ... The report also provides company shares and distribution shares ...
Breaking Medicine Technology: